BULLA, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 14.970
EU - Europa 8.281
AS - Asia 6.890
SA - Sud America 833
Continente sconosciuto - Info sul continente non disponibili 708
AF - Africa 220
OC - Oceania 33
AN - Antartide 1
Totale 31.936
Nazione #
US - Stati Uniti d'America 14.678
SG - Singapore 2.509
IT - Italia 1.722
PL - Polonia 1.501
CN - Cina 1.410
DE - Germania 980
SE - Svezia 924
VN - Vietnam 702
BR - Brasile 625
HK - Hong Kong 613
RU - Federazione Russa 548
UA - Ucraina 542
GB - Regno Unito 497
FR - Francia 385
KR - Corea 380
BD - Bangladesh 327
FI - Finlandia 292
NL - Olanda 220
TR - Turchia 195
IN - India 171
IE - Irlanda 168
CA - Canada 145
BG - Bulgaria 130
JP - Giappone 94
MA - Marocco 71
AR - Argentina 70
TW - Taiwan 64
MX - Messico 62
ID - Indonesia 56
BE - Belgio 54
CH - Svizzera 51
ZA - Sudafrica 48
AT - Austria 47
IQ - Iraq 43
ES - Italia 40
IR - Iran 33
AE - Emirati Arabi Uniti 31
PK - Pakistan 31
SA - Arabia Saudita 31
EC - Ecuador 29
PH - Filippine 29
CL - Cile 27
AU - Australia 26
CZ - Repubblica Ceca 26
VE - Venezuela 25
PT - Portogallo 23
EG - Egitto 22
SN - Senegal 22
UZ - Uzbekistan 22
IL - Israele 20
CO - Colombia 19
MY - Malesia 19
RO - Romania 19
TH - Thailandia 19
HU - Ungheria 16
LT - Lituania 16
AZ - Azerbaigian 15
PE - Perù 14
TT - Trinidad e Tobago 14
DK - Danimarca 13
PY - Paraguay 13
CR - Costa Rica 12
HN - Honduras 11
DZ - Algeria 10
GR - Grecia 10
JM - Giamaica 10
TN - Tunisia 10
JO - Giordania 9
NG - Nigeria 9
OM - Oman 9
SI - Slovenia 9
EU - Europa 8
MD - Moldavia 8
PA - Panama 8
EE - Estonia 7
GE - Georgia 7
KE - Kenya 7
LB - Libano 7
NP - Nepal 7
GT - Guatemala 6
HR - Croazia 6
LV - Lettonia 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
RS - Serbia 6
BO - Bolivia 5
CI - Costa d'Avorio 5
ET - Etiopia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LK - Sri Lanka 5
NO - Norvegia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
KW - Kuwait 4
SV - El Salvador 4
AM - Armenia 3
BB - Barbados 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 31.195
Città #
Ashburn 1.634
Singapore 1.514
Warsaw 1.348
Fairfield 1.267
Woodbridge 1.081
Ann Arbor 882
San Jose 792
Houston 773
Chandler 724
Hong Kong 575
Wilmington 548
Dallas 540
Seattle 530
Trieste 496
Jacksonville 444
Cambridge 424
Seoul 367
Beijing 344
Council Bluffs 331
Hefei 293
Boardman 244
Princeton 228
Santa Clara 224
Los Angeles 218
Columbus 202
Ho Chi Minh City 199
Chicago 194
New York 160
Hanoi 148
Dublin 144
The Dalles 134
Moscow 133
Izmir 132
Sofia 128
Lauterbourg 123
Zgierz 115
Milan 112
Helsinki 108
Buffalo 107
London 101
Frankfurt am Main 96
Munich 80
Dearborn 71
San Diego 70
São Paulo 64
Shanghai 60
Taipei 58
Casablanca 53
Tokyo 53
Atlanta 49
Dong Ket 49
Falls Church 49
Phoenix 49
North Bergen 45
Bern 43
Rome 43
Düsseldorf 42
Brussels 40
Boston 38
Da Nang 38
Orem 35
Toronto 35
Montreal 34
Washington 34
Turku 33
Amsterdam 32
Des Moines 32
Guangzhou 31
Menlo Park 31
Redmond 31
Redondo Beach 31
Miano 30
Stockholm 30
Nuremberg 29
Redwood City 29
San Francisco 28
Venice 27
Vienna 27
Chennai 26
Denver 26
Saint Petersburg 26
Brooklyn 25
Nanjing 25
Miami 24
Fort Wayne 23
Haiphong 23
Jakarta 23
Jinan 23
Dakar 22
Johannesburg 22
Lappeenranta 22
Kyiv 21
Poplar 21
Arzene 20
Baghdad 20
Treviso 20
Rio de Janeiro 19
Tashkent 18
Belo Horizonte 17
City of London 17
Totale 20.193
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 866
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 524
RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? 495
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 446
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 410
HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1 376
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 372
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 361
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 343
C1q is involved in human trophoblast invasion 329
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 329
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 324
Analysis of anti-C1q antibodies in normal and pathological pregnancies 320
Pre-eclampsia affects procalcitonin production in placental tissue 319
Pathological significance and prognostic value of surfactant protein D in cancer 316
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 312
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 309
C1q is associated with a reduced inflammatory response of decidual endothelial cells 308
C1q is responsible of the anti-inflammatory behavior of decidual endothelial cells 296
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 296
C1q: A novel angiogenic factor? 292
Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells 284
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 284
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 279
Alternative functions of the complement protein C1q at embryo implantation site 271
The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. 266
null 263
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 262
MALIGNANT PLEURAL MESOTHELIOMA WITH “SIGNETRING” CELLS: A DIAGNOSTIC CHALLENGE AND AN UNUSUAL CASE REPORT 261
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 260
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 260
Combined extracts of Echinacea angustifolia DC. and Zingiber officinale Roscoe in softgel capsules: Pharmacokinetics and immunomodulatory effects assessed by gene expression profiling 259
Analysis of the cAMP-PCT-CGRP axis in normal and pathological pregnancy 257
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 257
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 248
Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules 248
The role of complement component C1q in angiogenesis 242
Evaluation of Sars-CoV-2 entry receptors in COVID-19 positive and negative placentae: correlation between expression and infectivity 242
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 240
Placental trophoblast and endothelial cells as target of maternal immune response. 239
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia 235
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP 231
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 231
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 218
THE CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCES OF C1Q EXPRESSION IN GLIOMAS: A BIOINFORMATICS ANALYSIS 216
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 216
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 216
Preeclampsia is associated with defective production of C1q by invasive trophoblast 206
In vivo distribution of {beta}2 glycoprotein I under various pathophysiological conditions 205
Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating 204
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 204
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 204
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 203
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 199
Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells 199
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 198
A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients 197
Emerging Roles of the Complement System at Foeto-maternal Interface 197
The complement system at the embryo implantation site 197
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine 196
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 195
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 194
Analysis of the molecular mechanisms of C1-inhibitor deficiency induced angioedema 193
Overview of procalcitonin in pregnancy and in pre-eclampsia 193
Differential capability of clinically employed dermal regeneration scaffolds to support vascularization for tissue bioengineering 192
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 190
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 190
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 189
Complement activation in animal and human pregnancies as a model for immunological recognition 188
[The maternal-fetal immune relationship in pregnancy] 185
Surfactant protein D in immune surveillance against cancer 184
Prevalence and biological effects of anti-trophoblast and anti-endothelial cell antibodies in patients with recurrent spontaneous abortions. 183
A non-redundant role of complement protein C1q in normal and adverse pregnancy 179
Human eosinophil peroxidase enhances tumor necrosis factor and hydrogen peroxide release by human monocyte-derived macrophages 179
Proangiogenic properties of complement protein C1q can contribute to endometriosis 178
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 177
Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels 177
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 177
Prognostic Implications of the Complement Protein C1q in Gliomas 177
C1q as pro-angiogenic factor in the context of ovarian tissue transplantation 176
Endothelial cell supplementation promotes xenograft revascularization during short-term ovarian tissue transplantation 176
At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy Success 176
The Complement System at the Embryo Implantation Site: Friend or Foe? 175
The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system 174
C1q induces in vivo angiogenesis and promotes wound healing 173
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 170
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 167
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 166
”Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflamation”F.Fischetti, R. Carretta, G. Borotto, P. Durigutto, R. Bulla, P.L. Meroni, F. Tedesco. 165
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells 162
COVID-19, Pre-Eclampsia, and Complement System 162
Effect of a standardized liver and spleen fraction of peptides on the differentiation of human monocyte derived macrophages. 161
null 161
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 161
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment 160
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 159
null 159
Terminal Complement Complex: Regulation of Formation and Pathophysiological Functions 158
Study of the prognostic significance of the protein C1q in carcinomas 158
Pathophysiology of the Complement System at Feto-Maternal Interface 157
Totale 24.033
Categoria #
all - tutte 87.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.725 0 0 138 123 77 174 113 86 241 191 136 446
2022/20232.400 232 326 177 345 213 401 32 211 273 32 108 50
2023/20241.828 148 97 154 119 158 203 307 265 58 75 136 108
2024/20253.654 81 126 282 263 330 349 248 205 509 456 371 434
2025/20269.874 972 618 772 934 812 823 1.435 280 983 1.247 587 411
2026/20271.423 615 542 266 0 0 0 0 0 0 0 0 0
Totale 31.936